Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-09-28
1998-03-24
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, A61F 200, A61K 4700, A61K 31685, A61K 3800
Patent
active
057312842
ABSTRACT:
The present invention relates generally to methods for treating injury or degeneration of basal forebrain cholinergic neurons by administering glial cell line-derived neurotrophic factor (GDNF). The invention relates specifically to methods for treating Alzheimer's disease.
REFERENCES:
patent: 4518584 (1985-05-01), Mark et al.
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 5011472 (1991-04-01), Aebischer et al.
patent: 5106627 (1992-04-01), Aebischer et al.
patent: 5252714 (1993-10-01), Harris et al.
patent: 5639275 (1997-06-01), Baelge et al.
patent: 5641749 (1997-06-01), Yan et al.
patent: 5641750 (1997-06-01), Louis
Varon et al., (1979) Ann. Rev. Neurosci., 1:327-361.
Thoenen et al., (1985) Science, 229:238-242.
Thoenen et al., (1991) Trends Neurosci., 14:165-170.
Lapchak et al., (1993) Rev. Neurosci., 3:1-10.
Bothwell, (1995) Ann. Rev. Neurosci., 18:223-253.
Chao, (1995) TINS, 18:321-326.
Venero et al., (1993) Neuroreport 4:959-962.
Hefti, (1994) J. Neurobiol. 25:1418-1435.
Olson, (1994) Neurochem. Jul. 15:1-3.
Batchelor et al., (1989) J. Comp. Neurol. 284:187-204.
Kiss et al., (1988) Neurosci. 27:731-748.
Woolf et al., (1989) Neurosci. 30:143-152.
Lin et al., (1993) Science 260:1130-1132.
Krieglstein et al., (1995) EMBO J. 14:736-742.
Poulsen et al., (1994) Neuron 13:1245-1252.
Hudson et al., (1995) Brain Res. Bull. 36:425-432.
Beck et al., (1995) Nature 373:339-341.
Tomac et al., (1995) Nature 373:335-339.
Hoffer et al., (1994) Neurosci. Lett. 182:107-111.
Oppenheim et al., (1995) Nature 373:344-346.
Zurn et al., (1994) Neuroreport 6:113-118.
Yan et al., (1995) Nature 373:341-344.
Henderson et al., (1994) Science 266:1062-1064.
Miller et al., (1994) Soc. Neurosci. Abstr. 20:1300.
Selkoe, (1991) Neuron. 6:487-498.
Gage et al., (1986) Neurosci. 19:241-255.
Hagg et al., (1989) Brain Res. 505:29-38.
Hefti, (1986) J. Neurosci. 6:2155-2162.
Springer et al., (1987) J. Neurosci. Res. 17:111-118.
Sofroniew et al., (1993) J. Neurosci. 13:5263-5276.
Knusel et al., (1992) J. Neurosci. 12:4391-4402.
Koliatsos et al., (1994) J. Comp. Neurol. 343:247-262.
Koliatsos et al., (1991) Ann. Neurol. 30:831-840.
Morse et al., (1993) J. Neurosci. 13:4146-4156.
Venero et al., (1994) Neurosci. 59:797-815.
Widmer et al., (1993) Neuroreport 4:363-366.
Williams et al., (1989) Brain Res. 498:243-256.
Williams et al., (1986) Proc. Natl. Acad. Sci. USA 83:9231-9235.
Phelps et al., (1989) Neurobiol. Aging 10:205-207.
Olson, (1994) Neurochem. Jul. 25:1-3.
Olson et al., (1992) J. Neural Transm. 4:79-95.
Petty et al., (1994) Ann. Aug. 36:244-246.
Hagg et al., (1989) Neurosci. 30:95-103.
Rylett et al., (1993) J. Neurosci. 13:3956-3963.
Lapchak, (1993) Exp. Neurol. 124:16-20.
Butcher et al., (1989) Neurobiol. Aging 10:557-570.
Woolf et al., (1994) Neurosci. Sep. 62:327-331.
Della Seta er al., (1994) Pharmacol. 49:701-705.
Lewin et al., (1993) Trends Neurosci. Sep. 16:353-359.
Williams et al. (1991) Exp. Neurol. 113:31-37.
Hefti et al., (1993) Adv. Pharmacol. 24:239-273.
Fischer et al., (1994) Proc. Natl. Acad. Sci. USA 91:8607-8611.
Schmidt-Kastner et al., (1994) Mol. Brain Res. 26:325-330.
Schaar et al., (1993) Exp. Neurol. 124:368-371.
Schaar et al., (1994) Exp. Neurol. 130:387-393.
Dayhoff, (1972) Atlas of Protein Sequence and Structure 5:124.
Cunningham et al., (1989) Science 244:1081-1085.
Malik et al., (1992) Exp. Hematol. 20:1028-1035.
Francis, (1992) Focus on Growth Factors 3(2):4-10.
Chamow et al., (1994) Bioconjugate Chem. 5:133-140.
Winn et al., (1991) Exper. Neurol. 113:322-329.
Aebischer et al., (1991) Exper. Neurol. 111:269-275.
Tresco et al., (1992) ASAIO 38:17-23.
Kearns et al., (1995) Brain Res., 672:104-111.
Stromberg et al., (1995) Exp. Neurol. 124:401-412.
Schrier et al., (1967) Neurochem. 14:977-985.
Smolen, Ed. Conn, (1990) Neurosciences 3:208-229.
Emmett et al., (1995) Brain Res. 673:199-207.
Alderson, (1995) Eur. J. Neurosci.
Amgen Inc.
Curry Daniel R.
Levy Ron K.
Odre Steven M.
Touzeau P. Lynn
LandOfFree
Method for treating Alzheimer's disease using glial line-derived does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating Alzheimer's disease using glial line-derived, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating Alzheimer's disease using glial line-derived will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2288951